Observationen i ELITE I- undersøgelsen, at losartan reducerede risikoen for dødsfald sammenlignet med captopril, blev ikke bekræftet i den efterfølgende ELITE II- undersøgelse, som beskrives nedenfor.
The observation of the ELITE I Study, that, compared with captopril, Losartan reduced the mortality risk, was not confirmed in the subsequent ELITE II Study, which is described in the following.